-
Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma
Angelini Industries announces the appointment of Jacopo Andreose as new Chief Executive Officer of Angelini Pharma, a pharmaceutical company active in brain health, including mental health and epilepsy, and consumer healthcare, which is part of the Angelini Industries, an Italian multi-business group.
-
How the EPA Builds the N List
If you’re a healthcare provider or oversee infection control at your facility, you’ve probably become aware of the EPA’s “N” List, which specifies registered disinfectants approved for use against SARS-CoV-2. However, you may have wondered how the list is developed, and how exactly to interpret its phrasing. We’re here to help.
-
Angelini Pharma Acquires Arvelle In Historic Merger
Angelini Pharma and Arvelle Therapeutics have agreed on the 4th January 2021 a definitive merger agreement valuing Arvelle Therapeutics at up to $960 million.
-
International Infection Prevention Week 2020
On October 18th, a week devoted to celebrating the work of infection preventionists (IPs) begins worldwide. In these difficult times, IPs have been guiding the frontline healthcare workers — and often suiting up right alongside them — to slow the spread of COVID-19.